Japanese evaluation between FormuLa of Azelnidipine and amlodipine add on olmesartan to Get antialbuminuric effect study.

Trial Profile

Japanese evaluation between FormuLa of Azelnidipine and amlodipine add on olmesartan to Get antialbuminuric effect study.

Completed
Phase of Trial: Phase III

Latest Information Update: 13 May 2016

At a glance

  • Drugs Amlodipine (Primary) ; Azelnidipine (Primary) ; Olmesartan medoxomil
  • Indications Hypertension
  • Focus Pharmacodynamics
  • Acronyms J-FLAG
  • Most Recent Events

    • 25 Apr 2012 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 01 Aug 2011 Design and rationale published in the Cardiovascular Drugs and Therapy.
    • 19 Jan 2010 Planned number of patients changed from 500 to 250 as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top